Bioactive Toxin-Derived Peptides Antimicrobial & Antimycotic Peptides Custom Research Peptides Nuclear Localization Signals (NLS) Cell-Penetrating Peptides (CPPs) Alzheimer's & Parkinson's Therapeutic Development Melanogenesis Modulation Anti-Aging & Skin Remodeling Ligand-Directed Targeting Peptides Somatostatin Analogs Kinase Activity Modulators Apoptotic Enzymes Viral Protease Substrates Antiviral Peptides Antimicrobial Peptides Cardiovascular Peptides Immunomodulatory Peptides Thyroid Hormone-Related Insulin/Metabolic Regulation Parathyroid Hormone (PTH) Growth Hormone GnRH Analogues/Antagonists Pain and Inflammation Modulation Pituitary Hormones Neurotransmitters/Neuropeptides Standard Fmoc-Amino Acids D-Form Amino Acids Resins Condensation Agents Organic Building Blocks Pseudoproline Dipeptides Phenylalanine & Tryptophan Unusual Amino Acids & Analogs Newly Launched Small-Molecule Specialties Impurity Analysis & Bioactivity Research Special Offers Peptide Synthesis Chemical Synthesis ADMET Profiling Service AlanMolecularAI AlanDockAI Linear Peptide Optimization Cyclic Peptide Optimization Task Management Knowledge Center News About Us Reagents & Custom Orders Aipower Platform
Sign in
Cart
Search
Home Product Peptide Catalog Products Custom Research Peptides gp100 (177-186)

DESCRIPTION

gp100 (177 - 186) is a 10 - amino acid peptide fragment derived from the glycoprotein 100 (gp100), which is expressed by melanoma cells. This specific sequence is recognized as an antigenic epitope by the immune system, particularly by cytotoxic T lymphocytes (CTLs). In the context of immunotherapy, gp100 (177 - 186) is of great interest. It can be used to stimulate the immune response against melanoma. Vaccines incorporating this peptide aim to prime CTLs to recognize and destroy melanoma cells that display the gp100 antigen on their surface. Research involving gp100 (177 - 186) focuses on optimizing its immunogenicity, understanding how it interacts with major histocompatibility complex (MHC) molecules for antigen presentation, and improving the effectiveness of melanoma immunotherapies by enhancing the CTL - mediated killing of tumor cells.

Chemical Formula: C45H76N12O15S2

Molecular Weight: 1089.31

Sequence: Ala-Met-Leu-Gly-Thr-His-Thr-Met-Glu-Val

Purity: From crude to 98%

If there are no products available iwth the required purity and quantity, please inform us of your specifications and send an email to sales@alanscientific.com

Our representitives will respond within 24 hours

Research Use Only

gp100 (177-186)

Catalog No: AS2687

{{ getShowPrice() }} {{ getPrice() }}

Add to Cart Bulk Inquiry
{{ isCollect ? 'Cancel collection' : 'Collection' }}

Related Products

Submit